Journal article
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: A systematic review with statistical and cost-effectiveness modelling
R Perera, E McFadden, J McLellan, T Lung, P Clarke, T Pérez, T Fanshawe, A Dalton, A Farmer, P Glasziou, O Takahashi, J Stevens, L Irwig, J Hirst, S Stevens, A Leslie, S Ohde, G Deshpande, K Urayama, B Shine Show all
Health Technology Assessment | Published : 2015
DOI: 10.3310/hta191000
Abstract
Background Various lipid measurements in monitoring/screening programmes can be used, alone or in cardiovascular risk scores, to guide treatment for prevention of cardiovascular disease (CVD). Because some changes in lipids are due to variability rather than true change, the value of lipid-monitoring strategies needs evaluation. Objective To determine clinical value and cost-effectiveness of different monitoring intervals and different lipid measures for primary and secondary prevention of CVD. Data sources We searched databases and clinical trials registers from 2007 (including the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, the Clinical Trials Register, the Current Con..
View full abstractGrants
Funding Acknowledgements
The National Institute for Health Research Health Technology Assessment programme.